• 1
    Burgert EO,Nesbit ME,Garnsey, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup Study IESS-II. J Clin Oncol. 1990; 8: 15141524.
  • 2
    Nesbit ME,Gehan EA,Burgert EO, et al. Multimodal therapy for the management of primary nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup Study. J Clin Oncol. 1990; 8: 16641674.
  • 3
    Craft AW,Cotterill S,Bullimore JA,Pearson D. Long-term results from the first UKCCSG Ewing's tumour study (ET-1). Eur J Cancer. 1997; 33: 10611069.
  • 4
    Elomaa I,Blomqvist CP,Saeter G, et al. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol. Eur J Cancer. 2000; 36: 875880.
  • 5
    Paulussen M,Ahrens S,Dunst J, et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol. 2001; 19: 18181829.
  • 6
    Oberlin O,Deley MC,Bui BN, et al. French Society of Paediatric Oncology. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer. 2001; 85: 16461654.
  • 7
    Grier HE,Krailo MD,Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003; 348: 694701.
  • 8
    Bacci G,Ferrari S,Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol. 2000; 39: 111116.
  • 9
    Bacci G,Forni C,Longhi A, et al. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004; 40: 7383.
  • 10
    Gobel V,Jurgens H,Etspuler G, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol. 1987; 113: 187191.
  • 11
    Hryniuk W,Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol. 1984; 2: 12811288.
  • 12
    Barbieri E,Frezza G,Martelli O, et al. Non conventional fractionation in radiotherapy of the musculo-skeletal sarcomas. Tumori. 1998; 84: 167170.
  • 13
    Picci P,Bohling T,Bacci G, et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol. 1997; 15: 15531559.
  • 14
    Hayes FA,Thompson EJ,Meyer WH, et al. Therapy for localized Ewing's sarcoma of bone. J Clin Oncol. 1989; 7: 208213.
  • 15
    Aparicio J,Munarriz B,Pastor M, et al. Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution. Oncology. 1998; 55: 2026.
  • 16
    Givens SS,Woo SY,Huang LY, et al. Non-metastatic Ewing's sarcoma: twenty years of experience suggests that surgery is a prime factor for successful multimodality therapy. Int J Oncol. 1999; 14: 10391043.
  • 17
    Mirra JM. Bone tumors: clinical, radiologic and pathologic correlations. Philadelphia: Lea & Febiger; 1989: 1090.
  • 18
    Campanacci M. Bone and soft tissue tumors. Wien: Springer; 1990: 509.
  • 19
    Siegel RD,Ryan LM,Antman KH. Adults with Ewing's sarcoma: an analysis of 16 patients at the Dana-Farber Cancer Institute. Am J Clin Oncol. 1988; 11: 614617.
  • 20
    Sincovics JG,Plager C,Ayala AG,Lindberg RD,Samuels ML. Ewing sarcoma: its course and treatment in 50 adult patients. Oncology. 1980; 37: 114119.
  • 21
    Klassen R,Sastregarau X,Aurias A, et al. Sarcoma d'Ewing osseoux de l'adulte. Etude anatomoclinique de 30 observations. Bull Cancer. 1992; 79: 161167.
  • 22
    Verril MW,Judson IR,Wiltshaw E,Thomas JM,Harmer CL,Fisher C. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997; 8: 10901105.